Colitis, ulcerative Trials in Chevy Chase, United States
Conditions / Colitis, ulcerative / Chevy Chase, United States
Research into Colitis, ulcerative spans multiple therapeutic approaches and trial phases.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05242484 | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT05369832 | An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice | TERMINATED | PHASE4 |
| NCT00676832 | Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE2 |
| NCT03662542 | A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE2 |
| NCT01240915 | A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis | COMPLETED | PHASE2 |
| NCT02620046 | A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease | COMPLETED | PHASE3 |
| NCT02611830 | Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT07196748 | A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis | RECRUITING | PHASE3 |
| NCT02497469 | An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT01294410 | Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE2 |